EPITHELIAL MARKERS IN PANCREATIC-CARCINOMA - IMMUNOPEROXIDASE LOCALIZATION OF DD9, CEA, EMA AND CAM 5.2

被引:12
作者
HEYDERMAN, E [1 ]
LARKIN, SE [1 ]
ODONNELL, PJ [1 ]
HAINES, AMR [1 ]
WARREN, PJ [1 ]
NORTHEAST, A [1 ]
GRANT, AG [1 ]
机构
[1] ST GEORGE HOSP,DEPT SURG,LONDON,ENGLAND
关键词
D O I
10.1136/jcp.43.6.448
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Paraffin wax embedded, formalin fixed sections of 22 adenocarcinomas of the exocrine pancreas were stained with four mouse monoclonal antibodies: DD9-E7, an antibody raised against a human pancreatic tumour xenograft; carcinoembryonic antigen (CEA); epithelial membrane antigen (EMA); and cytokeratin (CAM 5.2). An indirect immunoperoxidase technique without enzyme pre-digestion and an affinity-purified sheep anti-mouse peroxidase conjugate were used. All of the tumours were positive for DD9-E7, EMA, and CAM 5.2. Twenty out of 22 were focally positive for CEA and the staining was often weak. As all of these adenocarcinomas were DD9-E7 positive, absence of staining for DD9-E7 in a tumour makes the diagnosis of adenocarcinoma of the exocrine pancreas very unlikely, and this is of value in distinction from endocrine carcinomas with a marked acinar pattern. The weak CEA staining distinguished pancreatic carcinomas from colorectal tumours. Because the distribution of staining for EMA and CAM 5.2 was no different from that previously seen in adenocarcinomas from other sites, these markers are likely to be of limited value in the differential diagnosis of abdominal adenocarcinomas of uncertain origin.
引用
收藏
页码:448 / 452
页数:5
相关论文
共 48 条
[1]   IMMUNOHISTOCHEMISTRY OF CEA IN THE HUMAN-PANCREAS DURING DEVELOPMENT, IN THE ADULT, CHRONIC-PANCREATITIS, AND PANCREATIC ADENOCARCINOMA [J].
ALBERS, GHR ;
FLEUREN, G ;
ESCRIBANO, MJ ;
NAP, M .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1988, 90 (01) :17-22
[2]   DEMONSTRATION OF CARCINOEMBRYONIC ANTIGEN (CEA) EXPRESSION IN NORMAL, CHRONICALLY INFLAMED, AND MALIGNANT PANCREATIC TISSUE BY IMMUNOHISTOCHEMISTRY [J].
ALLUM, WH ;
STOKES, HJ ;
MACDONALD, F ;
FIELDING, JWL .
JOURNAL OF CLINICAL PATHOLOGY, 1986, 39 (06) :610-614
[3]  
ATKINSON BF, 1982, CANCER RES, V42, P4820
[4]   MONOCLONAL-ANTIBODIES AGAINST CEA-RELATED COMPONENTS DISCRIMINATE BETWEEN PANCREATIC DUCT TYPE CARCINOMAS AND NONNEOPLASTIC DUCT LESIONS AS WELL AS NONDUCT TYPE NEOPLASIAS [J].
BATGE, B ;
BOSSLET, K ;
SEDLACEK, HH ;
KERN, HF ;
KLOPPEL, G .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1986, 408 (04) :361-374
[5]  
BOROWITZ MJ, 1984, J NATL CANCER I, V72, P999
[6]  
BURTIN P, 1973, J IMMUNOL, V111, P1926
[7]   SURVIVAL IN 1001 PATIENTS WITH CARCINOMA OF THE PANCREAS [J].
CONNOLLY, MM ;
DAWSON, PJ ;
MICHELASSI, F ;
MOOSSA, AR ;
LOWENSTEIN, F .
ANNALS OF SURGERY, 1987, 206 (03) :366-373
[8]   PRODUCTION OF MONOCLONAL-ANTIBODIES AGAINST HUMAN EPITHELIAL MEMBRANE ANTIGEN FOR USE IN DIAGNOSTIC IMMUNOCYTOCHEMISTRY [J].
CORDELL, J ;
RICHARDSON, TC ;
PULFORD, KAF ;
GHOSH, AK ;
GATTER, KC ;
HEYDERMAN, E ;
MASON, DY .
BRITISH JOURNAL OF CANCER, 1985, 52 (03) :347-354
[9]  
CUBILLA AL, 1984, ATLAS TUMOR PATHOL, P125
[10]   CARCINOEMBRYONIC ANTIGEN (CEA) IN GASTROINTESTINAL AND EXTRAGASTROINTESTINAL TUMORS AND ITS RELATIONSHIP TO TUMOR-CELL DIFFERENTIATION [J].
DENK, H ;
ECKERSTORFER, R ;
TAPPEINER, G ;
HOLZNER, JH .
INTERNATIONAL JOURNAL OF CANCER, 1972, 10 (02) :262-+